QRG Capital Management Inc. Decreases Holdings in Henry Schein, Inc. $HSIC

QRG Capital Management Inc. trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.7% in the second quarter, Holdings Channel reports. The firm owned 2,936 shares of the company’s stock after selling 246 shares during the period. QRG Capital Management Inc.’s holdings in Henry Schein were worth $214,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of HSIC. Rakuten Securities Inc. purchased a new stake in shares of Henry Schein during the 1st quarter valued at about $34,000. Steph & Co. purchased a new stake in shares of Henry Schein during the 2nd quarter valued at about $44,000. CX Institutional raised its holdings in shares of Henry Schein by 107.3% during the 2nd quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after buying an additional 337 shares during the period. TD Private Client Wealth LLC raised its holdings in shares of Henry Schein by 103.0% during the 2nd quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock valued at $49,000 after buying an additional 339 shares during the period. Finally, Whittier Trust Co. raised its holdings in shares of Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company’s stock valued at $55,000 after buying an additional 700 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Evercore ISI upgraded Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price on the stock in a report on Tuesday, August 26th. Weiss Ratings reiterated a “hold (c)” rating on shares of Henry Schein in a report on Wednesday, October 8th. UBS Group lowered their price objective on Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Leerink Partners set a $75.00 price objective on Henry Schein in a research note on Monday, July 14th. Finally, Barrington Research restated an “outperform” rating and set a $78.00 price objective on shares of Henry Schein in a research note on Tuesday, September 23rd. Five equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Henry Schein has a consensus rating of “Hold” and a consensus target price of $76.67.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $63.17 on Monday. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The business has a 50 day moving average price of $67.48 and a two-hundred day moving average price of $68.80. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm has a market cap of $7.66 billion, a PE ratio of 20.38, a price-to-earnings-growth ratio of 2.08 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.Henry Schein’s revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.